Workflow
介入器械
icon
Search documents
康德莱控股股东拟转让股份引入战略投资者
Zheng Quan Ri Bao Wang· 2025-09-03 08:45
本报记者 金婉霞 9月2日晚间,上海康德莱企业发展集团股份有限公司(以下简称"康德莱")发布公告称,公司控股股东上海康德莱控股集 团有限公司与长沙械字号医疗投资有限公司(以下简称"长沙械字号")于9月1日签署了《股份转让协议》,拟将其持有的公司 无限售流通股2183.95万股(占公司总股本的5%)以每股10.81元的价格转让给长沙械字号,转让总价2.36亿元。 康德莱方面认为,本次协议转让后,公司将会获得战略方的产业与资源协同,扩展在消费医疗领域的发展空间,增强公司 的市场竞争力,优化股权结构并提升公司治理。 康德莱是国内医用穿刺器械行业龙头企业,其主营业务产品包括医用穿刺针、输注器械、介入器械等。近年来受医疗器械 带量采购影响,行业竞争加剧,企业利润空间受到压缩。体现到财务数据上,2023年至2024年,其核心产品穿刺护理类产品的 销售收入分别为17.86亿元、16.07亿元,分别同比下降8.07%、10.03%,这也致使康德莱在2023年、2024年出现了营业收入的大 幅下滑。2025年上半年,康德莱对产品结构进行了调整,营业收入勉强回升。公司2025年中报数据显示,上半年,康德莱实现 营业收入11.25 ...
康德莱股价涨5.06%,招商基金旗下1只基金位居十大流通股东,持有327.11万股浮盈赚取150.47万元
Xin Lang Cai Jing· 2025-09-01 05:22
数据显示,招商基金旗下1只基金位居康德莱十大流通股东。招商量化精选股票发起式A(001917)二 季度减持251.36万股,持有股数327.11万股,占流通股的比例为0.75%。根据测算,今日浮盈赚取约 150.47万元。 招商量化精选股票发起式A(001917)成立日期2016年3月15日,最新规模27.65亿。今年以来收益 37.35%,同类排名744/4223;近一年收益73.66%,同类排名928/3780;成立以来收益268.66%。 招商量化精选股票发起式A(001917)基金经理为王平。 9月1日,康德莱涨5.06%,截至发稿,报9.55元/股,成交1.94亿元,换手率4.76%,总市值41.71亿元。 资料显示,上海康德莱企业发展集团股份有限公司位于上海市嘉定区高潮路658号,成立日期1998年7月 1日,上市日期2016年11月21日,公司主营业务涉及从事医用穿刺针、医用输注器械、介入器械等医疗 器械的研发、生产、销售和服务。主营业务收入构成为:穿刺护理类63.43%,标本采集类13.96%,其 他类13.23%,医美类5.30%,穿刺介入类4.08%。 从康德莱十大流通股东角度 风险提示: ...
康德莱股价涨5.06%,国寿安保基金旗下1只基金位居十大流通股东,持有421万股浮盈赚取193.66万元
Xin Lang Cai Jing· 2025-09-01 05:22
9月1日,康德莱涨5.06%,截至发稿,报9.55元/股,成交1.93亿元,换手率4.76%,总市值41.71亿元。 资料显示,上海康德莱企业发展集团股份有限公司位于上海市嘉定区高潮路658号,成立日期1998年7月 1日,上市日期2016年11月21日,公司主营业务涉及从事医用穿刺针、医用输注器械、介入器械等医疗 器械的研发、生产、销售和服务。主营业务收入构成为:穿刺护理类63.43%,标本采集类13.96%,其 他类13.23%,医美类5.30%,穿刺介入类4.08%。 从康德莱十大流通股东角度 数据显示,国寿安保基金旗下1只基金位居康德莱十大流通股东。国寿安保智慧生活股票A(001672) 二季度持有股数421万股,持股数量与上期相比不变,占流通股的比例为0.96%。根据测算,今日浮盈 赚取约193.66万元。 国寿安保智慧生活股票A(001672)成立日期2015年9月1日,最新规模18.28亿。今年以来收益 38.43%,同类排名687/4223;近一年收益86.88%,同类排名608/3780;成立以来收益225.05%。 国寿安保智慧生活股票A(001672)基金经理为张琦。 截至发稿,张琦累计 ...
江宁上半年省市重大项目全部开工
Nan Jing Ri Bao· 2025-07-23 23:42
Group 1 - Jiangning District has completed 36 projects and introduced new projects with a total investment exceeding 56 billion yuan in the first half of the year [1][2] - The Tianyin Health Innovation Park has been fully constructed, attracting nearly 10 companies in the biopharmaceutical sector, with a total building area of 395,000 square meters [1] - The high-end cosmetics production base and Huakang Zhenyan headquarters project, with a total investment of 1 billion yuan, will produce 25 million sets of cosmetics annually upon completion [2] Group 2 - Jiangning High-tech Zone successfully introduced 33 quality projects with a total investment of 10 billion yuan in the first half of the year, maintaining a leading position among high-tech zones in the city [2][3] - The Binjiang Economic Development Zone has signed 24 projects with investments over 1 billion yuan, totaling 4.02 billion yuan, and all major projects have resumed construction [3] - Jiangning District is focusing on a detailed monthly schedule to accelerate the development of major enterprises and improve project approval efficiency by 38% [4]
奖项评选延期!第二届全球医疗科技大会
思宇MedTech· 2025-06-06 12:26
Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [12]. - Participants must fill out a specific form or send an email with required details to apply for the awards [13]. Group 4: Evaluation Criteria - The awards are aimed at various entities including medical device companies, healthcare institutions, and service providers, with criteria focusing on originality, advanced technology, clinical application, and industry impact [7][10][11]. - Specific standards are set for each award category, emphasizing the need for innovative products or technologies that demonstrate clear clinical efficacy and potential for widespread application [10][11]. Group 5: Conference Agenda - The conference will cover topics such as global medical technology development trends, research and transformation paths for imaging platforms, new consumables, brain-machine interfaces, interventional devices, diagnostic equipment, and the integration of AI in healthcare [6]. - It will also address capital market interests in technology directions and enterprise profiles, as well as overseas market access and marketing strategies [6].
奖项评选延期!第二届全球医疗科技大会
思宇MedTech· 2025-06-05 18:08
Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical device field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, 2025, with results to be announced between June 30 and July 4, 2025 [11]. - The awards will be presented on July 17, 2025, after the confirmation of trophy production [11]. Group 4: Target Audience and Standards - The awards target various entities including medical device and digital health technology companies, clinical doctors, researchers, and key suppliers, with specific standards for originality, advancement, and potential for industrialization [7][10].
奖项评选延期!第二届全球医疗科技大会
思宇MedTech· 2025-06-05 10:08
Core Viewpoint - The deadline for the award application for the Global MedTech Innovation Awards has been extended to June 20, 2025, to allow more time for participants to prepare and submit their materials, aiming to showcase innovations and contributions in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of approximately 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference will feature a main stage for showcasing and awarding global medical technology innovations [5]. Group 2: Award Categories - The awards to be presented include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application and Evaluation Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4, and the awards to be presented on July 17, 2025 [11]. - Participants must meet specific criteria based on their roles, such as medical device companies, clinical doctors, researchers, and service providers, ensuring that the innovations are original, advanced, and have potential for large-scale industrialization [7][10].
奖项评选延期!医疗企业速来!第二届全球医疗科技大会
思宇MedTech· 2025-06-04 09:26
Core Viewpoint - The article announces the extension of the application deadline for the Global MedTech Innovation Awards to June 20, 2025, to allow more time for participants to prepare their submissions and showcase their innovations in the medical technology field [1]. Group 1: Event Overview - The Global MedTech Conference 2024 will take place on July 17, 2025, at the Zhongguancun Exhibition Center in Beijing, with an expected attendance of around 500 participants from various sectors including government, hospitals, leading enterprises, startups, investment institutions, and research institutes [5]. - The conference aims to highlight and award groundbreaking achievements in medical technology, with a focus on innovation, application, and service contributions [4][8]. Group 2: Award Categories - The awards include: 1. 2025 Global MedTech Innovation Award 2. 2025 Global MedTech Clinical Application Award 3. 2025 Global MedTech Service Contribution Award 4. 2025 Global MedTech Supply Chain Excellence Award 5. 2025 Global MedTech Innovation & Translation Award (Individual) [4][8]. Group 3: Application Process - The application phase is open from now until June 20, 2025, followed by a review phase from June 21 to June 29, with results to be announced between June 30 and July 4 [11]. - Participants must submit specific documents including a personal resume, a summary of research achievements, and any relevant supporting materials [13].